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ABSTRACT 
 
Understanding the molecular events in palate development is a prerequisite to 
more effective treatments of cleft palate. The secondary palate in humans and mice 
forms from shelves of mesenchyme covered with medial edge epithelium (MEE). These 
shelves adhere to form the midline epithelial seam (MES). MES cells then proceed 
through epithelial to mesenchymal transition (EMT) and/or apoptosis to yield a fused 
palate. Adhesion of opposing MEE is a crucial event whose alteration causes cleft palate. 
Previous studies showed that chondroitin sulphate proteoglycans (CSPG) on the apical 
surfaces of MEE was an important factor in palatal shelf adhesion. In this study we 
investigated decorin and biglycan, being expressed in numerous craniofacial tissues, as 
potential proteoglycans involved in palatal shelf adhesion. 
We used a laser capture microdissection (LCM) technique to collect MEE cells  
and real-time polymerase chain reaction, to determine mRNA levels of decorin and 
biglycan that correctly reflect changes in gene expression during various stages of 
palatal shelf fusion (Embryonic days 13.5, 14.0 and 14.5). Both decorin and biglycan 
were expressed on the apical surface as well as between the MEE cells. We found that 
biglycan protein and mRNA levels peaked as the palatal shelves adhered. Decorin on the 
other hand was less abundant on the surface and had reduced mRNA levels that might be 
due to the regulatory effects of TGFβ. Nevertheless, the temporal expression of both 
decorin and biglycan on the apical surface of MEE was suggestive of an important role 
in palatal adhesion. 
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NOMENCLATURE 
 
BGN Biglycan 
CDC                            Centers for Disease Control and Prevention 
CSPG Chondroitin sulphate proteoglycan 
DCN Decorin 
E 13.5                          Embryonic day 13.5 
EMT                           Epithelial to mesenchymal transformation 
ECM                           Extracellular matrix 
GAG                           Glycosaminoglycan 
GD                              Gestational day 
LCM Laser capture microdissection 
LLR                             leucine-rich repeats 
MEE Medial edge epithelia 
MES Midline epithelia seam 
mRNA                         Messenger RNA 
SLRP                           Small leucine-rich proteoglycan  
TGF-β                          Transforming growth factor β 
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CHAPTER I  
INTRODUCTION  
 
Cleft lip and cleft palate are among the most common craniofacial birth defects. 
The Centers for Disease Control and Prevention (CDC) estimates that each year in the 
United States, about 2,650 babies are born with a cleft palate and 4,440 babies are born 
with a cleft lip with or without cleft palate [1]. The management of cleft lip/palate 
requires an integrative multidisciplinary approach involving surgery, extensive dental 
treatment and speech therapy. The treatment thus, has a substantially elevated medical 
care costs.  
The process of palatogenesis is similar in mice and human beings. The process 
starts at E11.5 (week 6-7 of human fetal development) when the secondary palate arises 
as paired outgrowths form the maxillary process. They initially grow vertically and 
undergo palatal shelf elevation above the dorsum of the tongue (E13.5). After elevation, 
the paired palatal shelves grow towards the midline (E.14.0). The medial edge 
epithelium (MEE) that covers the shelf tip adheres forming the midline epithelial seam 
(MES) (E 14.5, week 9-10 of human fetal development). This is followed by 
disappearance of the MES by epithelial to mesenchymal transition (EMT) and/or 
apoptosis to allow mesenchymal confluence (E15.5) [2]. By E17 (week 12 of human 
fetal development) the palatine bone has formed and the development of the palate is 
complete. Adhesion of MEE of the opposing palatal shelves is a critical step, failure of 
which will result in cleft palate.  
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Immediately before adhesion changes occur in the superficial MEE cells to favor 
the contact of palatal shelves. It becomes multilayered [3]. In addition its most apical 
cells bulge and develop filopodia and microvilli [4, 5]. Furthermore, its apical 
extracellular matrix composition varies by synthesizing adhesion associated molecules 
such as fibronectin, vinculin [6] and chondroitin sulphate proteoglycans [7]. Even 
though palatal shelf adhesion is an essential event whose alteration causes cleft palate, it 
was investigated by only few studies [6]. 
The formation of the secondary palate is a complex process in which many 
factors are involved: transcription factors, cytokines, growth factors, and extracellular 
matrix molecules including proteoglycans [8]. Proteoglycans (PGs) are molecules 
composed of a specific core protein covalently linked to glycosaminoglycan (GAG) 
chains. The point of attachment is a Serine residue to which the glycosaminoglycan is 
joined through a tetra saccharide bridge to the core protein. They commonly mediate the 
interactions of ECM components with growth factors and cytokines[9]. Chondroitin 
sulphate proteoglycans (CSPG) are involved in important cell processes, such as cell 
adhesion, cell growth, receptor binding, cell migration and interaction with other 
extracellular matrix molecules. A previous study demonstrated that a CSPG coat on the 
apical surfaces of MEE is an important  factor in palatal shelf adhesion [10]. Not only 
does it appear on the apical surface of MEE cell immediately before palatal shelves 
contact (Figure 1) [7], but also a reduction in CSPG alters palatal shelve adhesion [7]. In 
addition, CSPG expression is controlled by TGF-β3, a growth factor that plays an 
important role in triggering palate shelf adhesion and fusion [7, 11]. Because the 
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monoclonal antibody used in that study was an anti-chondroitin sulphate antibody, the 
core protein associated with CSPG on the apical surfaces of MEE was not identified. 
 
 
 
 
Figure 1 E14.5 palatal shelves immunolabeled with anti-CSPG monoclonal antibody. (A) 
Palatal shelves far from each other. (B) As palatal shelves approach each other. Source: Gato, A. 
et al, 2002 [7]. 
 
 
 
Small leucine-rich repeat proteoglycans (SLRPs) is a family of structurally 
related proteoglycans. Members of this family are characterized by a small protein core, 
consisting predominately of leucine-rich repeats (LRR). The LRR motif mediates 
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protein-protein interactions and is accountable for the many interactions that define their 
function [12] . The family is divided to five classes depending on genomic organization 
and protein structure (Table 1).  
 
 
Table 1 Classes and structure of small leucine-rich repeat proteoglycan (SLRP) family 
members 
Class SLRP member Number of LRR GAG  type 
I Decorin, Biglycan, Asporin, ECM2 12 CS/DS 
II Fibromodulin, Lumican, PRELP, Keratocan 
Osteomoduli 
12 KS 
III Epiphycan, Opticin, Osteoglycin 8 DS & KS 
IV Chondroadherin, Nyctalopin, Tsukushi 12 Not Examined 
V Podocan, Podocan-like protein 20 Not Examined 
 
CS, chondroitin sulfate; DS, dermatan sulfate; KS, keratan sulfate. (Dellett et al, 2012). 
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Biglycan and decorin belong to class 1 of this family and have either one 
(decorin) or two (biglycan) small chondroitin/dermatan sulphate side chains. The 
expression of decorin and biglycan overlaps in both skeletal and non-skeletal tissues 
[13]. In the craniofacial region, biglycan and decorin are present in various tissues 
including cranial sutures [13], teeth [14], periodontal tissue [15, 16], temporomandibular 
joint [17], palate epithelia and mesenchyme during palatogenesis [8]. Decorin null mice 
show an abnormal skin fragility due to reduced tensile strength [18].The collagen fibers 
of the null animal are both loosely packed and exhibit irregular contours. Biglycan null 
animals show reduced bone mass and osteoporosis-like phenotype [19]. BGN/DCN 
double deficient mice have a further severe phenotype in both long bones and skin [20] 
compared to the wild type or single deficient mice, suggestive of functional 
compensation. The double knockout models the phenotype of Ehlers-Danlos syndrome 
in humans. It is an inherited disease that affects connective tissue and characterized by 
reduced tensile strength and integrity of skin, joints, and other structures. The progeroid 
variant of the disease results from mutation of the enzyme necessary for the 
posttranslational glycosylation of biglycan and decorin, resulting in the secretion of 
abnormal protein cores [21]. 
 Both decorin and biglycan have a broad binding repertoire, they can bind other 
ECM molecules such as collagens [18, 22] where they have an organizing function on 
the assembly of the extracellular matrix. Furthermore, they are important players in cell 
signaling capable of affecting cellular functions such as proliferation, differentiation, 
adhesion and migration [23].They can bind and modify the bioactivity of growth factors, 
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particularly those that belong to the transforming growth factor-β ligand super family 
[16, 24, 25]. Despite their presence in the palatal tissue during palatogenesis, nothing is 
known about their function and role in palatal shelf adhesion. Our observations lead us 
to hypothesize that decorin and biglycan, in participation with other proteoglycans, play 
an essential role in palatal shelf adhesion. 
To investigate this hypothesis we utilized Laser Capture Microdissection (LCM). 
The use of LCM allows to successfully isolate medial edge epithelia (MEE) cells of the 
fetal palatal shelves [26, 27]. We processed LCM–procured MEE cells for isolation of 
BGN and DCN mRNA during various stages of palate development for quantitative 
analysis using real-time PCR. The sensitivity and accuracy of the technique had been 
verified [26-28]. Furthermore, we performed immunohistochemical analysis to evaluate 
the distribution of BGN and DCN in the developing palates. 
In this study, we were able to identify a function for BGN and DCN in the palatal 
adhesion process. Our results provide evidence that they are expressed in a time-based 
manner in the palatal epithelia during development. 
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CHAPTER II 
MATERIALS AND METHODS 
 
Animals and dissection 
 Timed-pregnant CD-1 mice (Charles Rivers Laboratories,Inc) were used for 
these studies. Pregnant mice of the appropriate gestation age (GDs 13.5-14.5) were 
euthanized by Isoflurane inhalation followed by cervical dislocation. Fetuses were 
removed by caesarian section and placed into cold phosphate buffer saline (PBS). Under 
sterile conditions, fetuses’ mandibles were removed. To preserve RNA quality all 
procedures were performed as quickly as possible. Fetuses intended for 
immunohistochemical analysis were fixed in Carnoy’s fixative for one hour and allowed 
to sink in 30% sucrose overnight. 
Cryoembedding and cryosectioning 
 Fetuses were mounted in OCT embedding medium (Tissue-Tek), snap frozen 
using liquid nitrogen and stored at -80°C until sectioning. Before sectioning, the blocks 
were equilibrated to the cryostat temperature (-20°C) for 15 min. Fetuses were sectioned 
in the coronal plane to a thickness of 8 µm and mounted onto HistoBond slides for 
immunohistochemical analysis or PEN membrane slides (Leica) for LCM. PEN 
membrane Slides were stored at -80°C in slide boxes with Drierite dessicant. 
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Staining and laser capture microdissection 
 Immediately before performing LCM, sections were stained with Histogene 
LCM Frozen Section Staining Kit (Arcturus) to identify the palatal epithelia, following 
manufacture’s protocol. Stained dehydrated sections were then immediately processed 
for LCM. Using the built-in software of the Leica LMD 7000 (Leica Microsystems) cells 
of the palatal MEE were laser-captured and allowed to drop into a sterile PCR collecting 
tube cap containing 50µl of lysis buffer.  
Isolation and characterization of RNA from LCM-procured cells 
LCM-procured MEE cell from an average of 20-25 sections at a single stage of 
differentiation were pooled. Total RNA was extracted using RNAqueous Micro kit 
(Ambion/Life Technologies), sample were treated with DNase I to remove genomic 
DNA contamination. Extracted RNA quality and quantity was evaluated using 
NanoDrop 2000c Spectrophotometer (Thermo Fisher Scientific). 
Real-time PCR analysis 
To synthesize complementary DNA (cDNA) from RNA, the iScript™ Reverse  
Transcription Supermix for RT-qPCR (Bio-Rad Laboratiries, Inc.) was used. Due to the 
low number of cells in the MEE collected by LCM, a preamplification step was used 
following cDNA synthesis and before real-time PCR. A matched pool of BGN, DCN 
and GAPDH PrimePCR preamplification assays (Bio-Rad Laboratiries, Inc.) combined 
with SsoAdvanced™ PreAmp Supermix (Bio-Rad Laboratiries, Inc.) was used for this 
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step, as described by the manufacturer. Real-time PCR was undertaken on CFX96 Optics 
Module with the gene specific primer sets (Bio-Rad Laboratiries, Inc.). Data was 
analyzed using Bio-Rad CFX Manager 3.1 software. 
Bgn: Unique Assay ID: qMmuCID0014565. 
DCN: Unique Assay ID: qMmuCID0039628. 
GAPDH: Unique Assay ID: qMmuCED0027497. 
Decorin and biglycan immunohistochemistry 
 The specificity of the rabbit antisera against mouse DCN (LF-113) and BGN 
(LF-159) used in this study was established [29]. The antibodies were kindly provided 
by Dr. Larry W. Fisher (National Institute of Dental Research, NIH, MD). Sections were 
washed briefly in 0.1 M sodium acetate-0.1 M Tris-HCl buffer (pH 7.3). To enhance 
signal strength sections were then exposed for 60 min at 37ºC to 0.42 U/ml protease-free 
chondroitinase ABC from Proteus vulgaris (Sigma-Aldrich Co. LLC). Sections were 
incubated with the primary antibody overnight with a dilution of 1:200. Sections were 
then reincubated for two hours with goat anti-rabbit IgG secondary antibody, Alexa 
Fluor 488 conjugate (1:500 dilution). TO-PRO (Life Technologies) was used for nuclear 
counter staining. Samples were analyzed using Leica TCS SP II Confocal Microscope. 
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CHAPTER III 
RESULTS 
 
Decorin and biglycan quantitative real-time PCR 
 During palate formation, the palates elevate horizontally at E13.5. By E14.0 the 
palatal shelves juxtapose. Finally by E14.5 they fuse and the midline edge epithelium 
covering each of the palatal shelves forms the midline epithelia seam. We laser captured 
the MEE and MES and compared the relative expression (normalized with Gapdh) of 
decorin and biglycan mRNA during these three stages (far, close and fused palatal 
shelves). When palatal shelves were far BGN expression level was low. As palatal 
shelves approached each other, there was a significant increase of more than 6 fold of 
relative BGN expression when compared to far palatal shelves. This was followed by a 
significant down regulation of BGN mRNA when the palatal shelves fused. Even though 
it was down regulated at this stage, it was still significantly upregulated by 2 fold when 
compared to far palatal shelves (Figure 2). 
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Figure 2 Biglycan mRNA relative expression during far, close and fused palatal shelves. 
The real-time PCR data, normalized with Gapdh are presented as mean ± SEM; *P<0.05; 
**P<0.01, compared to far palatal shelves. 
 
 
 
DCN mRNA expression levels were different from that of BGN. When 
compared to far palatal shelves, there was a significant down regulation of 2.5 and 5 fold 
of DCN mRNA in the close and fused palatal shelves respectively. In addition, there was 
a significant down regulation of around 2 fold of DCN mRNA in fused palatal shelves 
when compared to close ones (Figure 3). Because of the low levels of DCN and to 
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ascertain that we have the accurate RT-PCR settings, we added a positive control. DCN 
is highly expressed in the meninges around E13.5 [30].  
 
 
Figure 3 Decorin mRNA relative expression during far, close and fused palatal shelves. The 
real-time PCR data, normalized with Gapdh are presented as mean ± SEM; *P<0.05; **P<0.01, 
compared to far palatal shelves. 
 
     
 
Expression pattern of DCN and BGN in the palatal shelve epithelia 
 We performed immunohistochemical analysis of DCN and BGN expression on 
the palatal shelves epithelia on various stages of development. Both BGN and DCN 
were not detected on the palatal shelves medial edge epithelia when the palatal shelves 
were vertical (data not shown). At E13.5 the palatal shelves have elevated but are still far 
from each other, expression BGN is noticeable between the MEE cells but is not 
detected in MEE cells immunolabeled for DCN (Figure 4) 
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Figure 4  Confocal images of anti-BGN and anti-DCN immunolabeled far coronal palate 
sections. (A, B and D) Images of immunolabeled far palatal shelves for control, DCN and BGN 
respectively. (C and E) Higher magnification for the boxed area in B and D 
 
 
 
As the palatal shelves approach each other a thin layer of BGN and DCN is 
noticed around and on the apical surface of the medial edge epithelia (Figure 5). BGN 
expression is more intense than DCN at this stage. 
BGN                      DGN 
DCN                        B Control                       A C 
E 
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Figure 5  Confocal images of anti-BGN and anti-DCN immunolabeled approaching palate 
sections. Expression of BGN and DCN intensifies in the MEE of approaching palatal shelves. 
(A, B and D)  Images of immunolabeled palatal shelves for control, DCN and BGN respectively. 
(C and E) The boxed area is shown at a higher magnification in which BGN and DCN are 
detected in the apical surface of MEE (arrows). 
 
 
 
Palatal shelves at point of close contact show abundant expression of BGN and 
DCN in between and on the surface of MEE (Figure 6). The bulging MEE cells become 
covered with BGN to the point of contact (Figure 7). As the palatal shelves fuse and 
DCN                         B 
BGN                          D 
Control                     A C 
E 
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MES is formed there is abundant expression of both DCN and BGN between the MES 
cells. The expression of the latter being more intense (Figure 8). 
 16 
 
 
Figure 6 Confocal images of anti-BGN and anti-DCN immunolabeled close palate sections 
(A, B, E) Images of immunolabeled palatal shelves for control, DCN and BGN 
respectively. (C) The boxed area in B is shown at a higher magnification. Arrows point to 
apically expressed DCN. (D and F) boxed area in E shown at a higher magnification. Arrows 
point to apically expressed BGN.  
 
 
 
 
 
Figure 7 Confocal image of anti-BGN immunolabeled close palate section without the 
nuclear counterstaining. Abundant accumulation of BGN on the apical surface of the MEE to 
the point of contact (arrows) 
 
DCN                 B 
BGN              E 
Control                      A C 
D F 
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Figure 8  Confocal images of anti-BGN and anti-DCN immunolabeled fused palate 
sections. (A, B, D) Images of immunolabeled palatal shelves for control, DCN 
and BGN respectively. (C and E) the boxed area in B and D is shown at a higher 
magnification. Arrows point to DCN and BGN localization between the MES cells. 
 
 
B 
E 
Control                       A C 
F 
DCN 
BGN 
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CHAPTER IV 
DISCUSSION AND CONCLUSION 
 
Lately, many genes have been studied for their role in palate formation, with 
most concentrating on the fate and disappearance of the MES. However, few studies 
focused on genes involved in the attachment of opposing palatal shelves. It had been 
established previously that expression of chondroitin sulphate proteoglycans on the 
apical surface of MEE cells is a key factor in palatal shelf adhesion [7]. 
In this study, we used the highly sensitive quantitative gene expression of LCM 
procured MEE / MES cells and immunohistochemistry analysis to demonstrate the 
expression of decorin and biglycan during palatal shelf adhesion. Both decorin and 
biglycan are localized between and on the surface of the MEE when palatal shelves start 
to adhere each other. This expression is intensified when the shelves are very close and 
more accumulation of the two proteoglycans surrounds the bulging MEE cells. 
Furthermore, the expression continues between the MES cells after fusion. However, 
biglycan was more intensely immunolabeled during all stages. The expression pattern on 
the surface is similar to that reported in a previous study [7], where they demonstrated 
the presence of a CSPG coat on the apical surface of the MEE as the palatal shelves 
adhere to each other, suggestive that DCN and BGN could be part of that glycolytic coat. 
However, in contrast to their study, our results show that both DCN and BGN were also 
expressed between the MEE cells in the cell-cell junction area. Decorin and biglycan, 
depending on the tissue, can have glycosaminoglycan (GAG) chains of either 
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chondroitin sulfate or dermatan sulphate [31]. This difference might be attributed to the 
anti-chondroitin sulphate monoclonal antibody CS-56 used in the previous study. It is 
reported to be specific for the GAG portion of native chondroitin, not dermatan, sulfate 
proteoglycan and hence might have not detected DCN or BGN. 
 The mRNA expression of DCN and BGN levels were dissimilar. Biglycan 
showed up regulation that had a peak when palatal shelves were very close. Decorin, on 
the other hand, was down regulated as the palates approached and when the palates fused 
and the MES was formed. Though structurally very similar, their mRNA expression 
patterns are suggestive of difference in regulation in palatogenesis. This is consistent 
with the only other study that investigated the expression of decorin and biglycan during 
palatogenesis [8]. Their results also demonstrated a difference in the regulation of both 
genes in response to retinoic-acid (RA) treatment. 
Transforming growth factor beta (TGFβs) signaling is essential for normal 
palatogenesis. All three isoforms play a role in the process, but two members are 
expressed in the MEE: TGFβ1 and TGFβ3. In the  mouse palate TGFβ3 is evident in the 
MEE as early as E.13.5 this expression increases as palatal shelves develop and ends 
when the MES disappears [32]. TGFβ3 knockout mice develop cleft palate, with an 
incidence of 100% [33]. In the knockout mice, the palatal shelves develop, elevate, and 
meet in the midline as in the wild type, but shortly afterwards they separate resulting in 
cleft palate [29]. Not only is TGFβ3 required for the adhesion and intercalation of the 
opposing MEE [3], but is inductive of the changes that occur in the MEE before fusion 
[4]. TGFβ1 expression is first observed at E14 in the MEE and in some isolated 
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mesenchymal palatal cells. The expression increases in both locations and disappears in 
the MES at the time of MES disappearance, persisting in the palatal mesenchyme in 
those areas of future ossification [32]. Several studies have shown that TGFβ1 has an 
active role in palatal fusion and that interaction between it and TGFβ3 occurs in the 
developing palate [11, 32, 34]. The binding of proteoglycans, including decorin and 
biglycan, to growth factors has recently been well recognized [35, 36]. Both decorin and 
biglycan bind TGFβ through their core protein [24, 37] affecting its bioactivity. 
Furthermore, TGFβ had been shown to affect the production of both proteoglycans in 
different ways.  
Biglycan is a member of the small leucine-rich proteoglycan family (SLRP) and 
its proposed function is dependent on its microenvironment [31] and hence a number of 
diverse functions have been attributed to it. In the blood vessels it had been shown to be 
involved in atherosclerotic plaques [38], in the skeleton it controls bone mass [19] and in 
the dentition biglycan affects amelogenesis [39]. Biglycan has also been shown to be 
expressed in cell surface and/or pericellulary [31, 40].The intense expression of BGN in 
the MEE of adhering palatal shelves further augments this pattern. Additionally, its 
expression on the apical surface of MEE greatly increases when contact between palatal 
shelves becomes imminent and at the point of contact (figure 6). The mRNA levels 
coincide with its protein pattern with an up regulation of its mRNA expression more 
than 6 fold when the palatal shelves are close to each other. The levels are then down 
regulated as the palatal shelves fuse and the MES is formed. This temporal expression of 
BGN in the apical surface of MEE of the fusing palatal shelves clearly demonstrates a 
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new function for BGN in palatal shelf adhesion. Biglycan expression can be modified by 
a number of growth factors including TGFβ. It had been shown that TGFβ  enhances 
BGN mRNA and protein expression in numerous cell types including human skin, 
kidney, lung fibroblast [41], articular cartilage [42] and bone [43].The temporal co-
expression of both BGN and TGFβ in the MEE cells as the palatal shelves adhere is 
suggestive that BGN expression is up regulated in the palatal epithelia as a result of 
TGFβ signaling. Further studies should be conducted to establish this relationship. 
Decorin is the other most widely known SLRP family member. Although 
structurally very related, decorin and biglycan show considerable difference both in their 
functions and expression regulation. Decorin functions include regulating collagen 
fibrillogenesis, ECM production, cell-cycle progression, programmed cell death, 
neovascularization and maintaining corneal transparency [44, 45]. Our results show that 
decorin was also detected in a similar pattern as BGN and was also expressed in the 
apical surface of the MEE however, the immunolabeling was less intense. Furthermore 
its mRNA levels showed a significant down regulation of 2.5 and 5 fold in close and 
fused palatal selves respectively. The lack of correlation between DCN mRNA levels 
and the protein levels could be explained by either a more efficient translational rate or a 
slow turnover rate of DCN protein. The fact that decorin is mostly found bound to 
collagen in the ECM supports the second explanation. It has been reported that a 
reciprocal relationship exists between decorin and TGFβ [46, 47]. In contrast to 
biglycan, TGFβ had been reported to down regulate the expression of DCN [42, 47, 48]. 
In chondrocytes it had been demonstrated that the decreased DCN levels induced by 
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TGFβ was due to transcriptional down regulation [48]. This is consistent with the 
decline in DCN mRNA and it’s coincident with the appearance of TGFβ expression in 
the MEE cells. Furthermore, previous studies have shown that decorin can interact with 
TGFβs through its core protein neutralizing its activity [26]. It was suggested that it 
forms complexes with TGFβ, sequesters the cytokine and prevents it from binding to its 
receptor [20, 24]. The improper sequestration of TGFβ in DCN/BGN double knockout is 
responsible for the osteoporotic bone phenotype [20]. Additionally, it was demonstrated 
that collagen-bound decorin is capable of sequestering TGFβ [49]. BGN, being located 
pericellularly, is less likely to trap the cytokine [35]. Moreover, as a result of this 
interaction decorin was studied as a potential therapeutic agent in treatment of TGFβ 
induced fibrosis (gene therapy) [50]. Hence, in palate adhesion, the transient expression 
of decorin and down regulation after fusion is required to allow for normal TGFβ 
expression and palatogensis process. Further studies will be required to conclusively 
establish the relationship between decorin and TGFβ in palatal adhesion. 
MES disappearance is required to allow mesenchymal confluence and thus an 
essential process for palatogenesis. The MES disappears by means of cell death [51], 
epithelial to mesenchymal transformation [52] and migration orally or nasally [53]. 
Epithelial to mesenchymal transformation (EMT) is an important phenomenon of wound 
healing, tumor metastasis and embryonic development including palatogenesis [54, 55]. 
It encompasses a number of events including reorganization of cytoskeleton and 
mobility of epithelial cells [56]. Furthermore the process is regulated by a number of 
growth factors including TGFβ and extracellular matrix molecules [57]. Both decorin 
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and biglycan had been reported to affect cellular adhesion and increase cellular 
migration [58, 59]. Decorin influences cellular adhesion through interaction with a 
number of ECM proteins. For example, DCN decreases cellular attachment to 
fibronectin [60] and thrombospondin[61]. In addition it can bind integrin α2β1 and act as 
a competitive inhibitor[62]. Decorin has been found to induce metalloproteinase 
synthesis including MMP-1,-2 and -14 [63]. MMPs are required for the ECM breakdown 
during epithelial to mesenchymal transformation process. Biglycan expression on the 
other hand, had been associated in recent studies with increased tumor invasiveness and 
association with EMT [64, 65]. Moreover, BGN up regulation parallels changes in 
morphology and gene expression associated with TGF-β-induced EMT. Our results 
clearly demonstrate that both DCN and BGN are expressed in the lateral cell membrane 
compartment in both MEE and MES. Their inductive cellular anti-adhesive and 
migratory properties and regulation by TGFβ is suggestive that they may be important in 
the morphological and cytoskeletal changes during EMT of the MEE cells. 
On a final note, neither DCN nor BGN single or double knockout transgenic 
mice develop cleft palate. Recently more factors had been discovered to play a role in 
palatal shelf adhesion. Examples include the glycoprotein fibronectin and its receptor 
α5β1-integrin, the cellular adhesion molecule nectin-1 [6] , the epithelial adhesion 
molecule CEACAM-1 [66] and the Src family kinases (SFK) [67]. The mouse knockout 
phenotype of some of these molecules also do not develop cleft palates suggesting that 
opposing MEE adhesion results from interaction of different cell adhesion molecules. 
 24 
 
These factors in addition to other undiscovered proteoglycans may compensate for the 
deficiency of DCN and BGN in these transgenic mice.  
In conclusion, our results were the first to characterize an expression pattern of 
decorin and biglycan on the MEE and MES during palatal adhesion, which is highly 
indicative of an important role in both palatal shelves adhesion and involvement in the 
EMT process. Though the two small chondroitin/dermatan sulphate proteoglycans are 
very similar in structure, they differ in the distribution and function during palatogenesis. 
This opens up the doors for more studies focusing on the regulation of decorin and 
biglycan in the palatal epithelia during adhesion and their interaction with TGFβ. 
 The discovery of new genes involved in this process will help in the 
understanding of palatal fusion and thus aid in the development of approaches to 
enhance it and improve treatment for cleft palate. 
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